Cell Harvesting System Market Overview
The Cell Harvesting System Market was valued at USD 6.75 Billion in 2025 and is projected to reach USD 14.37 Billion by 2032, growing at a CAGR of 11.4% during 2026–2032, with North America holding the largest share.
Primary Drivers
- Rapid expansion of cell and gene therapy pipelines, CAR-T manufacturing and regenerative medicine is driving demand for automated, closed-system cell harvesting.
- Rising stem cell research funding, biobanking activity and bone-marrow/adipose harvesting procedures are expanding both clinical and research end-use volumes.
- Shift from manual to automated, GMP-compliant closed harvesting platforms improves yield, viability and contamination control, supporting premium system and consumable sales.
Primary Challenges
- High capital cost of automated harvesting systems and associated single-use consumables restricts adoption in smaller labs and emerging markets.
- Stringent GMP, sterility and regulatory validation requirements for clinical-grade cell processing lengthen adoption cycles and raise compliance burden.
- Shortage of skilled cell-processing personnel, plus reimbursement uncertainty for cell and gene therapies, creates demand-side risk for capital equipment purchases.
This report includes a dedicated chapter covering supply chain exposure, export controls, sanctions risk, and regulatory shifts affecting Cell Harvesting System Market.
Cell Harvesting System Market Strategic Outlook
The cell harvesting is processes of collecting cell for transplant depends on the source of stem cell. Depending on the degree of confluence of the culture, and the harvesting technique, single cells or cell sheets can be harvested from the Cell Surface. Stem cell transplants includes restoring of blood-forming stem cells in cancer patient. A stem cell transplant is a treatment for leukemia, multiple myeloma, or some types of lymphoma, congenital diseases. Cell transplant can be :
- Autologous – Harvesting of Cell from patient itself (self donor)
- Allogeneic - Harvesting of Cell from someone else.
- Syngeneic - Stem cells come from patients identical twin.
Growth trajectory, 2026–2032
How this market is covered
Revenue split by type
Revenue by end use
Increase in number of cancer patient is the primary force driving Global Cell Harvesting System Market. Technological advancement with fast and easy procedure of cell harvesting and transplant results in tremendous growth for market. This report covers primary factors contributing for Harvesting System Market growth, Market Concentration Rate, Technology Trends in Future.
This study includes analysis of cell harvesting sources as :
- Umbilical Cord - A large number of stem cells are normally found in the blood of newborn babies. After birth, the blood that’s left behind in the placenta and umbilical cord (known as cord blood) can be taken and stored for later use in a stem cell transplant.
- Bone Marrow- Bone marrow is the spongy liquid tissue in the center of some body bones. It has a rich supply of stem cells, and Bone Marrow is responsible to make blood cells that circulate in your body. Stem cells are 70 times more concentrated in bone marrow than in peripheral blood.
- Peripheral Blood- peripheral blood stem cell transplant, the stem cells are taken from blood. A special thin flexible tube (called a catheter) is put into a large vein in the donor and attached to tubing that carries the blood to a special machine. The machine separates the stem cells from the rest of the blood, which is returned to the donor during the same procedure.
- Adipose tissue - Adipose tissue, or fat, is a medical term for loose connective tissue composed of adipocytes.
Global Cell Harvesting System Market: End User / Application Type
- Hospitals
- Clinics
- Academic institutes
- R&D centers.
Global Cell Harvesting System Market: Source Type
- Umbilical Cord
- Bone Marrow
- Peripheral Blood
- Adipose tissue
Global Cell Harvesting System Market: Key Player
- Argos Technologies, Inc.
- Perkin Elmer, Inc.
- Brand GmBh + CO KG
- Arthrex, Inc.
- Avita Medical
- Tomtec
- Terumo Corporation
- Teleflex, Inc.
- Bertin
Global Cell Harvesting System Market: Regional Analysis
-
North America
- U.S.A
- Canada
- Europe
- France
- Germany
- Spain
- UK
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South East Asia
- Latin America
- Brazil
- Middle East and Africa
Biotechnology Landscape
Report Coverage
| Parameter | Details |
|---|---|
| Base Year | 2025 |
| Historical Data | 2020 – 2025 |
| Forecast Period | 2026 – 2032 |
| Base Year Value | USD 6.75 Billion |
| Forecast Value | USD 14.37 Billion |
| CAGR | 11.4% |
| Regional Scope | North America · Europe · Asia-Pacific · Latin America · MEA · RoW |
Frequently Asked Questions
Cell Harvesting System Market was valued at USD 6.75 Billion in 2025 and is estimated to reach USD 14.37 Billion by 2032.
Cell Harvesting System Market is projected to grow at a CAGR of 11.4% during 2025–2032.
Cell Harvesting System Market is dominated by the segment and the region holds the highest market share in 2025.
Some of the top key players in the Cell Harvesting System Market are
1. Rapid expansion of cell and gene therapy pipelines, CAR-T manufacturing and regenerative medicine is driving demand for automated, closed-system cell harvesting. 2. Rising stem cell research funding, biobanking activity and bone-marrow/adipose harvesting procedures are expanding both clinical and research end-use volumes. 3. Shift from manual to automated, GMP-compliant closed harvesting platforms improves yield, viability and contamination control, supporting premium system and consumable sales.
Yes. The report includes a dedicated section on geopolitical risk factors and their impact on supply chains, pricing, and regional demand dynamics.